-
-
-
-
-
-
-
Aimmune Stock Trading Halted Today; FDA Allergenic Products Advisory Committee (APAC) Meeting to Discuss PALFORZIA™ (AR101) for Peanut Allergy
-
-
-
-
-
-
-
Aimmune Therapeutics (AIMT) Misses Q2 EPS by 7c
-
-
-
-
-
-
-
Aimmune to Participate in the Goldman Sachs 40th Annual Healthcare Conference
-
-
-
-
-
-
-
Aimmune Therapeutics Announces First Quarter 2019 Financial Results and Provides Operational Highlights
-
-
-
13,126 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All